Association and clinical significance of the thickness of fetal heart wall in the third trimester with the control status of HbA1c level among Gestational diabetes mellitus women
-
摘要:
目的观察孕晚期胎儿心脏室壁厚度与妊娠期糖尿病孕妇HbA1c水平控制状态的关联并讨论其临床意义。 方法随机择2015年1月~2019年6月我院接受孕检的罹患妊娠期糖尿病的122例单胎妊娠孕妇及其胎儿为研究对象。收集母亲孕早期、孕中期以及孕晚期HbA1c信息,借助超声检测收集孕晚期胎儿心室壁厚度信息等相关资料信息,分析孕晚期胎儿心脏室壁厚度与母亲孕期HbA1c水平控制状态的关联情况。 结果孕早期受试对象的HbA1c水平为(5.80±1.60)%,孕中期为(5.91±1.61)%,孕晚期为(5.97±1.86)%,3个时期测定水平差异无统计学意义(P>0.05),不同孕期HbA1c控制情况分布特征差异无统计学意义(P>0.05);孕早期、孕中期和孕晚期不同HbA1c控制水平的孕妇,在孕晚期经超声测定胎儿的心室壁厚度和室间隔厚度比较可见,孕早期和孕中期不同HbA1c控制水平的胎儿舒张晚期、收缩晚期左右心室以及室间隔的厚度差异无统计学意义,但是绝对数字可见血糖水平控制不佳的孕妇胎儿心室壁和室间隔厚度均相对更高;孕晚期母亲血糖水平对胎儿收缩晚期左心室壁厚度影响相对较大,孕晚期母亲HbA1c控制水平不佳者均可见胎儿收缩晚期左心室壁厚度更大(P < 0.05);孕晚期母亲HbA1c水平控制不良与孕晚期胎儿测定的舒张晚期左心室厚度、收缩晚期左心室厚度以及舒张晚期室间隔厚度呈正相关关系(r=0.404、0.361、0.332,P < 0.05)。 结论罹患妊娠糖尿病的孕妇,血糖控制不佳会影响引发胎儿心室壁和室间隔增厚,有可能对胎儿心脏发育造成不良影响,基于此建议尽量有效控制孕妇血糖水平处于良好范围,特别是孕晚期控制血糖水平,以便减低胎儿和新生儿的心脏损害。 Abstract:ObjectiveTo observe the correlation between the thickness of the fetal heart wall in the third trimester and the control status of HbA1c levels in pregnant women with diabetes in gestation and discuss its clinical significance. MethodsA total of 122 single pregnant women suffering from gestational diabetes and their fetuses in our hospital from January 2015 to June 2019 were randomly selected as the research objects. The maternal HbA1c information in the first, second and third trimester of pregnancy and the fetal ventricular wall thickness information in the third trimester of pregnancy were collected by ultrasound detection. The correlation between fetal heart wall thickness and maternal HbA1c level control state were analyzed during the pregnancy. Use SPSS software to complete statistical analysis. ResultsThe HbA1c level of the subjects in the first trimester in the study was (5.80±1.60)%, the HbA1c% level in the second trimester was (5.91±1.61)%, and the third trimester was (5.97±1.86)%. There was no significant difference between the three periods (P>0.05). No statistically significant differences were found in the distribution characteristics of HbA1c control during different pregnancy periods. Among pregnant women with different HbA1c control levels in the first, second and third trimesters of pregnancy, the fetal ventricular wall thickness and interventricular septal thickness were measured by ultrasound during the third trimester. It can be seen that the fetuses with different HbA1c control levels in the first and second trimesters have late diastolic and contractile. There is no statistically significant difference in the thickness of left and right ventricles and interventricular septum. But the absolute figures show that the fetal ventricular wall and interventricular septal thickness of pregnant women with poorly controlled blood glucose levels are relatively higher. Thickness has a relatively large impact. The results of this study show that the mothers with poor control of HbA1c in the third trimester can see that the left ventricular wall thickness in the late fetal contraction is greater (P < 0.05); on the basis of the foregoing analysis, this study uses related analysis, HbA1c level control in the second and third trimesters of pregnancy and fetal ventricular wall thickness measured in the third trimester were correlated, and the results suggest that poorly controlled HbA1c levels in the third trimester and the late diastole measured in the third trimester fetus Ventricular thickness, left ventricular thickness in late systole, and late diastolic septum thickness were positively correlated (r=0.404, 0.361, 0.332, P < 0.05). ConclusionPoor blood glucose control in pregnant women suffering from gestational diabetes can cause thickening of the fetal ventricular wall and septum, which may adversely affect the fetal heart development. Therefore, it is suggested that the blood glucose level of pregnant women should be controlled in a good range as far as possible, especially in the third trimester of pregnancy, so as to reduce the heart damage of fetus and newborn. -
表 1 受试对象基本特征分布[n(%)]
Table 1. The distribution feature for the participants
指标 年龄 < 35岁(n=107) 年龄>35岁(n=15) 合计(n=122) χ2/t P 孕前BMI(kg/m2, Mean±SD) 21.97±1.86 22.19±2.32 22.08±2.15 0.416 0.678 消瘦组 21 (19.63) 2(13.33) 23 (18.85) 0.438 0.932 正常组 56 (52.34) 8 (53.33) 64 (52.46) 超重组 23 (21.50) 4 (26.67) 27(22.13) 肥胖组 7 (6.54) 1 (6.67) 8 (6.56) 孕前血压(mmHg,Mean±SD) 舒张压 82.08±8.36 83.26±7.22 83.09±7.75 0.520 0.604 收缩压 119.09 ± 9.35 121.12 ± 11.09 120.47± 10. 15 0.769 0.443 表 2 受试对象孕期HbA1c水平控制情况分布
Table 2. The distribution of the HbA1c level among the pregnant women
时期 HbAlc (%, Mean±SD) 控制不佳[n(%)] 控制良好[n(%)] 孕早期 5.80±1.60 51 (41.80) 71 (58.20) 孕中期 5.91 ± 1.61 56 (45.90) 66 (54.10) 孕晚期 5.97 ± 1.86 55 (45.08) 67 (54.92) χ2/F 0.320 0.465 0.465 P 0.729 0.792 0.792 表 3 不同孕早期HbA1c水平孕母孕晚期胎儿心室壁厚度及相关参数分布特征(mm, Mean±SD)
Table 3. The status of fetal heart wall in the first trimester among different HbA1c level Gestational diabetes mellitus women
孕早期(12周以内) 合计水平(n=122) 控制不佳(n=51) 控制良好(n=71) χ2/t P 舒张晚期左心室壁厚度 2.53±0.51 2.54 ± 0.54 2.51 ± 0.47 0.162 0.872 收缩晚期左心室壁厚度 2.40±0.44 2.41 ± 0.47 2.39 ± 0.40 0.078 0.938 舒张晚期右心室壁厚度 2.61 ± 53 2.62 ± 0.52 2.59 ± 0.60 0.209 0.835 收缩晚期右心室壁厚度 3.26±0.60 3.28 ± 0.65 3.23 ± 0.52 0.110 0.913 舒张晚期室间隔厚度 3.31±0.56 3.32 ± 0.53 3.28 ± 0.60 0.138 0.890 收缩晚期室间隔厚度 4.62±0.53 4.63 ± 0.56 4.60±0.55 0.037 0.970 表 4 不同孕中期HbA1c%水平孕母孕晚期胎儿心室壁厚度及相关参数分布特征(mm, Mean±SD)
Table 4. The status of fetal heart wall in the middle trimester among different HbA1c level Gestational diabetes mellitus women
孕中期(12~28周) 合计水平(n=122) 控制不佳(n=56) 控制良好(n=66) χ2/t P 舒张晚期左心室壁厚度 2.58 ± 0.59 2.94± 0.60 2.86 ± 0.52 0.789 0.432 收缩晚期左心室壁厚度 2.46 ± 0.51 2.48 ± 0.53 2.45 ± 0.54 0.078 0.938 舒张晚期右心室壁厚度 2.65 ± 0.51 2.67 ± 0.54 2.60±0.47 0.209 0.835 收缩晚期右心室壁厚度 3.32 ± 0.61 3.34± 0.56 3.29 ± 0.64 0.110 0.913 舒张晚期室间隔厚度 3.35 ± 0.70 3.38 ± 0.62 3.31 ± 0.71 0.138 0.890 收缩晚期室间隔厚度 4.70±0.81 4.71 ± 0.86 4.69 ± 0.75 0.037 0.970 表 5 不同孕晚期HbA1c%水平孕母孕晚期胎儿心室壁厚度及相关参数分布特征(mm, Mean±SD)
Table 5. The status of fetal heart wall in the third trimester among different HbA1c level Gestational diabetes mellitus women
孕晚期(28周以后) 合计水平(n=122) 控制不佳(n=55) 控制良好(n=67) χ2/t P 舒张晚期左心室壁厚度 2.58 ± 0.59 2.94±0.60 2.45±0.49 1.957 0.053 收缩晚期左心室壁厚度 2.50±0.54 2.81±0.60 2.19±0.41 2.933 0.004 舒张晚期右心室壁厚度 2.68 ± 0.56 2.70±0.62 2.65±0.43 0.228 0.822 收缩晚期右心室壁厚度 3.36 ± 0.58 3.38±0.52 3.29±0.60 0.296 0.768 舒张晚期室间隔厚度 3.40±0.74 3.42±0.73 3.37±0.76 0.130 0.897 收缩晚期室间隔厚度 4.75 ± 0.71 4.77±0.68 4.68±0.75 0.237 0.813 表 6 不同孕晚期HbA1c控制水平孕母孕晚期胎儿心室壁厚度等及相关参数相关性的相关分析
Table 6. Correlation for the status of fetal heart wall in the third trimester and the HbA1c level for Gestational diabetes mellitus women
因素 孕早期HbAlc控制不良 孕中期HbAlc控制不良 孕晚期HbAlc控制不良 V P r P r P 舒张晚期左心室壁厚度 0.152 0.095 0.177 0.051 0.404 0.000 收缩晚期左心室壁厚度 0.098 0.283 0.159 0.080 0.361 0.000 舒张晚期右心室壁厚度 0.113 0.215 0.176 0.053 0.155 0.088 收缩晚期右心室壁厚度 0.175 0.054 0.069 0.450 0.128 0.160 舒张晚期室间隔厚度 0.163 0.073 0.133 0.144 0.332 0.001 收缩晚期室间隔厚度 0.075 0.412 0.128 0.160 0.104 0.254 -
[1] 黄时花.胎儿先天性心脏病的高危因素及产前超声筛查的意义[J].中国优生与遗传杂志, 2019, 27(5): 594-5. http://www.cnki.com.cn/Article/CJFDTotal-ZYYA201905029.htm [2] 郭艳军, 王华, 邹燕.孕前超重和肥胖对孕期糖脂代谢及妊娠结局的影响[J].中国计划生育学杂志, 2019, 27(6): 814-8. http://oldmed.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_hnyxyj201908023 [3] 万贝贝, 郑瑜, 鞠雪涛, 等.妊娠期糖尿病孕妇妊娠中期胎儿心脏功能超声评估[J].海南医学, 2019, 30(13): 1719-21. http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&filename=HAIN201913023 [4] 钟成秋, 万绪波.妊娠期糖尿病治疗对其后代儿童期肥胖症的影响[J].分子影像学杂志, 2018, 41(2): 241-4. doi: 10.3969/j.issn.1674-4500.2018.02.24 [5] 范浩亮, 牛志通, 崔杉杉.糖化血红蛋白研究进展与临床意义的探讨[J].中外医疗, 2012, 31(21): 186. http://d.wanfangdata.com.cn/Periodical/hgzy201221139 [6] 张向梅, 丁依玲.妊娠期糖代谢异常患者糖化血红蛋白测定的临床意义[J].中南大学学报:医学版, 2008, 33(1): 85-8. http://www.cnki.com.cn/Article/CJFDTotal-HNYD200801018.htm [7] 黄奔.糖化血红蛋白检测与临床应用新进展[J].临床检验杂志:电子版, 2018, 7(1): 168-70. https://www.zhangqiaokeyan.com/academic-journal-cn_health-care-guide_thesis/0201254132488.html [8] 王少婷, 刘倩, 于洋, 等.糖化血红蛋白的检测方法及标准化研究进展[J].中日友好医院学报, 2019, 33(1): 38-40, 44. http://www.cqvip.com/QK/97734X/20191/90828972504849574849484950.html [9] 张东红, 李强.糖化白蛋白与糖化血红蛋白比值的临床应用进展[J].中国全科医学, 2020, 23(17): 2105-9. http://www.cnki.com.cn/Article/CJFDTotal-QKYX202017003.htm [10] 宋志英, 董润楠.妊娠期糖代谢异常与巨大儿发生的相关因素分析[J].中国药物与临床, 2019, 19(7): 1042-4. http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zgywylc201907004 [11] 曹明满, 邢辉.妊娠合并糖代谢异常孕妇动态血糖图谱变化分析[J].中国计划生育学杂志, 2013, 21(5): 337-9, 342. http://qikan.cqvip.com/Qikan/Article/Detail?id=45799073 [12] 续靖宁, 黄长芳.妊娠早期糖化血红蛋白联合体质量指数筛查妊娠期糖尿病的临床价值[J].海南医学, 2019, 30(12): 1542-4. http://www.cnki.com.cn/Article/CJFDTotal-HAIN201912015.htm [13] 伍萍, 张瑜.超声在胎儿心功能检测中的应用价值[J].安徽医药, 2018, 22(6): 1139-41. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=ahyy201806036 [14] 曾秀梅, 梁元豪, 杜志成, 等.胎儿先天性心脏病的早孕期超声筛查及产前诊断结果分析[J].中华围产医学杂志, 2018, 21(11): 737-44. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhwcyxzz201811004 [15] 韩吉晶, 佟立, 卢瑜群, 等.正常胎儿心脏发育与孕周增长关系的初步探讨[J].临床超声医学杂志, 2010, 12(4): 245-8. http://d.wanfangdata.com.cn/Periodical/lccsyxzz201004009 [16] 王政平, 于金华, 缪伟, 等.孕期规范化超声检查对子宫内胎儿心脏发育异常筛查的临床意义[J].中国妇幼保健, 2016, 31(2): 430-2. http://www.cnki.com.cn/Article/CJFDTotal-YXYY201819113.htm [17] 王媛, 赵旭, 杨娅, 等.时间-空间相关成像联合组织多普勒超声观察妊娠期糖尿病孕妇胎儿心脏结构和功能[J].中国医学影像技术, 2019, 35(4): 573-7. http://www.cqvip.com/QK/98028X/20194/7001712218.html [18] 易婷华, 蔡东传, 黄桂, 等.探讨孕期不同时段超声检查对胎儿心脏畸形的诊断价值[J].吉林医学, 2019, 40(7): 1533-4. http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&filename=JLYX201907057 [19] 王晓东, 王燕, 李文婷.妊娠期糖尿病孕妇血糖控制情况及对胎儿畸形发生率的影响和相关性研究[J].中国优生与遗传杂志, 2019, 27 (4): 480-2, 476. http://www.cqvip.com/QK/98444X/20194/90898965504849574852485152.html [20] 柳伟伟, 丁科亮, 罗海霞, 等.妊娠期糖尿病孕妇不同血糖指标异常与妊娠结局的关系[J].临床和实验医学杂志, 2016, 15(2): 112-5. http://qikan.cqvip.com/Qikan/Article/Detail?id=48336502 [21] 王扬.糖化血红蛋白水平与妊娠期糖尿病孕妇生产结局的关系[J].中国计划生育和妇产科, 2018, 10(1): 37-9. http://www.cnki.com.cn/Article/CJFDTotal-JHFC201801010.htm [22] 秦庆新, 肖正华, 谢晓斌.妊娠期糖尿病孕妇酮体、肌醇含量变化与胎儿畸形的相关性[J].分子影像学杂志, 2016, 39(3): 229-31. doi: 10.3969/j.issn.1674-4500.2016.03.08 [23] 高云鹤, 郑海清, 殷彩欣, 等.妊娠期糖尿病患者糖化血红蛋白及血糖指标异常与妊娠结局的相关性[J].实用妇产科杂志, 2019, 35(3): 228-33. http://www.cnki.com.cn/Article/CJFDTotal-SFCZ201903023.htm [24] 董娟, 李晓琴.妊娠期糖尿病孕妇胎儿心脏构型及心功能评估研究[J].西南国防医药, 2018, 28(3): 212-4. http://www.cnki.com.cn/Article/CJFDTotal-XNGF201803006.htm [25] 洪小恒, 邝小玲, 周燕, 等.妊娠期糖尿病患者的糖化血红蛋白水平和体重指数对妊娠结局的影响[J].中外医学研究, 2019, 17(32): 1-4. http://d.wanfangdata.com.cn/periodical/zwyxyj201932002 [26] 胡桂朗, 李惠甄, 朱雅芸. Tei指数联合糖化血红蛋白对妊娠期糖尿病胎儿心脏功能的预测价值[J].中国医药科学, 2019, 9(24): 100-2, 113. http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&filename=GYKX201924028
计量
- 文章访问数: 873
- HTML全文浏览量: 345
- PDF下载量: 8
- 被引次数: 0